Live
ePaper
Search
Home > India > BRIEF-FDA Grants Medivir's MIV-711 Rare Pediatric Disease Designation For Osteogenesis Imperfecta

BRIEF-FDA Grants Medivir's MIV-711 Rare Pediatric Disease Designation For Osteogenesis Imperfecta

Written By:
Last Updated: November 19, 2026 13:32:33 IST

Nov 19 (Reuters) – Medivir AB: * MEDIVIR: FDA GRANTS MEDIVIR’S MIV-711 RARE PEDIATRIC DISEASE DESIGNATION FOR OSTEOGENESIS IMPERFECTA * MIV-711 MAY QUALIFY FOR PRIORITY REVIEW VOUCHER – TRANSFERABLE

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?